ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GWP GW Pharm.

735.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
GW Pharm. LSE:GWP London Ordinary Share GB0030544687 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 735.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

GW Pharmaceuticals PLC Holding(s) in Company (9985P)

24/11/2016 7:30am

UK Regulatory


TIDMGWP

RNS Number : 9985P

GW Pharmaceuticals PLC

24 November 2016

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                          GW Pharmaceuticals PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-------------------------------------------------------------  ------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
---------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
-----------------------------------------------------------------  --------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
-----------------------------------------------------------------  --------------------------------- 
 An acquisition or disposal of instruments with                                    x 
  similar economic effect to qualifying financial 
  instruments 
-----------------------------------------------------------------  --------------------------------- 
 An event changing the breakdown of voting rights 
-----------------------------------------------------------------  --------------------------------- 
 Other (please 
  specify): 
---------------------------------------------------------  ------  --------------------------------- 
 3. Full name of person(s)                                        The Goldman Sachs Group, Inc. 
  subject to the 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  --------------------------------------- 
 4. Full name of shareholder(s)                                    Goldman Sachs International 
  (if different from 3.):(iv)                                          Goldman, Sachs & Co. 
                                                                  Goldman Sachs Asset Management, 
                                                                               L.P. 
-----------------------------------------------------------  --------------------------------------- 
 5. Date of the transaction                                              18 November 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  --------------------------------------- 
 6. Date on which issuer                                                 22 November 2016 
  notified: 
-----------------------------------------------------------  --------------------------------------- 
 7. Threshold(s) that is/are                                                 Below 3% 
  crossed or 
  reached: (vi, vii) 
-----------------------------------------------------------  --------------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------------------ 
 Class/type        Situation previous              Resulting situation after the 
  of                to the triggering               triggering transaction 
  shares            transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
----------------  ------------------------------  ---------------------------------------------------------- 
                   Number          Number          Number    Number of                % of voting 
                   of              of              of         voting                   rights (x) 
                   Shares          Voting          shares     rights 
                                   Rights 
----------------  --------------  --------------  --------  -----------------------  ----------------------- 
                                                   Direct    Direct   Indirect        Direct   Indirect 
                                                             (xi)      (xii) 
----------------  --------------  --------------  --------  -------  --------------  -------  -------------- 
                                                                          Below                    Below 
   GB0030544687       94,532          94,532                                3%                       3% 
                  --------------  --------------  --------  -------  --------------  -------  -------------- 
 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------ 
 Type of           Expiration      Exercise/                 Number of voting         % of voting 
  financial         date            Conversion                rights that              rights 
  instrument        (xiii)          Period (xiv)              may be 
                                                              acquired if 
                                                              the 
                                                              instrument 
                                                              is 
                                                              exercised/ 
                                                              converted. 
----------------  --------------  ------------------------  -----------------------  ----------------------- 
                                                                    Below 3%                 Below 3% 
----------------  --------------  ------------------------  -----------------------  ----------------------- 
   C: Financial Instruments with similar economic effect 
     to Qualifying Financial Instruments 
     (xv, xvi) 
   ---------------------------------------------------------------------------------------- 
                     Resulting situation after the triggering transaction 
   ---------------------------------------------------------------------------------------- 
    Type of financial   Exercise   Expiration    Exercise/      Number        % of voting 
        instrument        price       date       Conversion    of voting      rights (xix, 
                                                   period        rights           xx) 
                                                               instrument 
                                                                 refers 
                                                                   to 
   ------------------  ---------  -----------  ------------  ------------  ---------------- 
                                                                            Nominal   Delta 
   ------------------  ---------  -----------  ------------  ------------  --------  ------ 
                                                                 Below                Below 
                                                                   3%                   3% 
   ------------------  ---------  -----------  ------------  ------------  --------  ------ 
------------------------------------------------------------------------------------------------------------ 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------ 
 Number of voting rights                           Percentage of voting rights 
------------------------------------------------  ---------------------------------------------------------- 
                    Below 3%                                               Below 3% 
------------------------------------------------  ---------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
---------------------------------------------------------------------------------------- 
 
   N/A 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------- 
 10. Name of the proxy holder:                                         N/A 
-------------------------------------------------------  ------------------------------- 
 11. Number of voting rights proxy                                     N/A 
  holder will cease 
  to hold: 
-------------------------------------------------------  ------------------------------- 
 12. Date on which proxy holder will                                   N/A 
  cease to hold 
  voting rights: 
-------------------------------------------------------  ------------------------------- 
 
                                                          General email contact: 
  13. Additional information:                              shareholderdisclosures@gs.com 
-------------------------------------------------------  ------------------------------- 
 14. Contact name:                                        Joanna Foley 
-------------------------------------------------------  ------------------------------- 
 
 15. Contact telephone number:                             +44 207 051 9996 
-------------------------------------------------------  ------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAPFDAEAKFFF

(END) Dow Jones Newswires

November 24, 2016 02:30 ET (07:30 GMT)

1 Year Gw Pharmaceuticals Chart

1 Year Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock